Ignite Creation Date:
2025-12-24 @ 11:29 PM
Ignite Modification Date:
2025-12-25 @ 9:16 PM
Study NCT ID:
NCT01510756
Status:
TERMINATED
Last Update Posted:
2016-01-21
First Post:
2012-01-11
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Sorafenib for the Treatment of Chronic Lymphocytic Leukemia (CLL)
Sponsor:
Thomas Kipps
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
110574
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |